Meliora Therapeutics Raises $11M Seed Financing To Develop First Mechanism Of Action Atlas In Oncology
Amount Raised
$11 Million
Round Type
Seed
San FranciscoBiotechnologyDescription
Meliora Therapeutics, a biotech company pioneering a machine learning-driven platform to decipher oncology drugs’ true mechanisms-of-action, announced today the close of an $11M seed financing round led by HOF Capital and ZhenFund, with participation from Obvious Ventures, Village Global, BrightEdge (the impact investment arm of the American Cancer Society), Pebblebed (fund of Keith Adams, former Chief Architect at Slack), Axial, Olive Capital, and prominent individual investors Michael Polansky (co-founder of Parker Institute for Cancer Immunotherapy and ArsenalBio), Wes Sterman (founding investor for Gilead), and others.
Quick answer
Meliora Therapeutics raised $11 Million in a Seed round, dated September 29, 2022. Meliora Therapeutics is based in San Francisco, California, United States.
- How much did Meliora Therapeutics raise?
- Meliora Therapeutics raised $11 Million in a Seed round on September 29, 2022.
- What does Meliora Therapeutics do?
- Meliora is reimagining modern cancer drug development by putting genomics and cutting-edge computational approaches as first class principles of product development.
- Where is Meliora Therapeutics based and how big is it?
- Meliora Therapeutics is based in San Francisco, California, United States.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Meliora Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- LUMINOPIA raised an undisclosed amount (Seed) on November 11, 2022.
- AcuraStem Inc raised $400K (Seed) on November 11, 2022.
- Serina Therapeutics raised $3.7M (Seed) on November 10, 2022.
- SQI Diagnostics raised $2M (Seed) on November 10, 2022.
- Lipidio Pharmaceuticals raised an undisclosed amount (Series A) on November 10, 2022.
- The Shape Sensing Company raised an undisclosed amount (Funding Round) on November 10, 2022.
Who to call at Meliora Therapeutics, and when
A new round usually means Meliora Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Meliora Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Meliora Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Meliora Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Meliora Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Meliora Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.